CANNARA BIOTECH INC.
Last · —$2.08-0.04 (-1.89%)live · yahoo · 8m ago
Vol 38.9K ≈ 80.1K
MA10MA20MA50
Market cap——
P/E · TTM18.9fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameCANNARA BIOTECH INC.
HQCanada (CA)
ListingCA LOVE
ISINCA13765U2002
SectorHealthcare
IndustryHealthcare Facilities & Services
CurrencyCAD
Entity registrytsx:LOVE
Org IDLOVE
Websitecannara.ca
Employees452
AddressCannara Biotech, Inc. 333 Décarie Boulevard H4N 3M9, Montréal +514 543 4200
Loading chart…
Upcoming earnings
MON.23NOV
1:30 PM UTC+1
Period
Aug 2026
Est. EPS
$0.04
Est. revenue
34.5M
Earnings transcripts
Press & signals
- GlobeNewswire
Cannara Expands International Supply Agreement with Curaleaf
- GlobeNewswire
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
- GlobeNewswire
Cannara Appoints Nicholas Fozard as Chief Financial Officer
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 1 of 1 filings